Ab­b­Vie's Covid-19 an­ti­body part­ner wraps $221M Hong Kong IPO

Just a few days af­ter Ab­b­Vie went all in on a Covid-19 an­ti­body, its part­ner has of­fi­cial­ly wrapped its IPO.

List­ing on the Hong …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.